E1 Detection as Prognosticator in Human Papillomavirus-Positive Head and Neck Cancers. Issue 2 (April 2016)

• Record Type: Journal Article
• Authors: Vivenza, Daniela; Lo Nigro, Cristiana; Denaro, Nerina; Fortunato, Mirella; Monteverde, Martino; Tonissi, Federica; Lattanzio, Laura; Astesana, Valentina; Gloghini, Annunziata; Volpi, Chiara C.; Russi, Elvio; Merlano, Marco C.
• Is Part Of: International journal of biological markers. Volume 31:Issue 2(2016)
• Page Start: 163
• Page End: 172
• Publication Date: 2016-04
• Subjects: DNA-PCR -- Human papillomavirus -- Oropharyngeal cancer -- Prognostic value -- p16-IHC; Cell receptors -- Periodicals; Histochemistry -- Periodicals; Tumor markers -- Periodicals; Tumor antigens -- Periodicals; 616.99407582
• DOI: 10.5301/jbm.5000193
• Languages: English
• ISSNs: 0393-6155

Abstract

Purpose: HPV-related locally advanced head and neck cancers (LA-HNCs) show a good prognosis. This study aimed to investigate the HPV prevalence in LA-HNCs and compare the prognostic value of E1, E6 and L1 genomic viral fragments and p16, individually and in combination, in order to find the best prognosticator in terms of overall survival (OS) and progression-free survival (PFS). Patients and Methods: HPV16 was searched in 255 LA-HNC formalin-fixed paraffin-embedded tumor tissues, 89 oropharyngeal cancers (OPCs), and 166 non-OPCs by DNA-PCR with 3 primer pairs. p16 was analyzed by immunohistochemistry in 235 patients. Results: The prevalence of positive samples decreased constantly from E6 to L1 and E1 in both OPCs and non-OPCs. Each LA-HNC patient highlighted variable positivity for each fragment. OPCs showed a higher prevalence of positive samples compared to non-OPCs. Positive coexistence of all the fragments was more common in OPCs (31.5%) than non-OPCs (4.2%), and E1 detection was always associated with E6 and L1. E1-positive OPCs showed improved OS (p = 0.012) and PFS (p = 0.036), while L1- or E6-positive ones did not. p16-positive patients were more prevalent in the OPC (29.8%) than the non-OPC group (7.3%) (p<0.0001) and its prognostic value was not superior to that of E1. However, the multivariate Cox analysis which included E1, L1, E6 status and p16 expression did not show a significant p value. Conclusions: Though HPV16 positivity measured by DNA-PCR was higher for L1 and E6, they performed weakly as prognosticators; E1 might become a strong prognostic marker for OS and PFS in OPCs.